Fred Middleton

Fred Middleton

Directeur/Bestuurslid bij
Actimis Pharmaceuticals, Inc.

Vermogen: 19 127 $ op 31-08-2026

76 jaar
Health Technology
Finance
Consumer Services

Profiel

Fred A. Middleton is Vice Chairman & Chief Business Officer at Altor BioScience Corp.
since 2005.
Managing Director at Sanderling Management CO LLC since 1988.
Director at Cylene Pharmaceuticals, Inc., Actimis Pharmaceuticals, Inc. since 2008, TheraVida, Inc., Lineagen, Inc. since 2008, Asteres, Inc. Member at MIT Corp.
since 2007.
Managing Director at Middleton, McNeil & Mills Associates V LLC and Mesa Verde Ventures LLC.
Formerly Chairman at Genteric, Inc. from 1978 to 2008.
Chief Financial Officer & Director at Regeneron Pharmaceuticals, Inc. from 1988 to 2001.
Director at Favrille, Inc. from 2002 to 2009.
Independent Director at CardioNet LLC in 2011.
Independent Director at Stereotaxis, Inc. from 2012 to 2018.
Director at Axikin Pharmaceuticals, Inc., CoMentis, Inc., HCW Biologics Inc. Director at Pacira Biosciences, Inc. in 2013.
Independent Director at Endocyte, Inc. from 2011 to 2018.
Director at ViaCyte, Inc. from 2020 to 2022.
Independent Director at Chimerix, Inc. from 2018 to 2025.
Independent Director at CalciMedica, Inc. from 2020 to 2026.
Chief Financial Officer & VP-Administration at Genentech, Inc. from 1978 to 1984.
Vice President-Planning & Development at The Chase Manhattan Bank NA in 1984.
Managing General Partner at Morgan Stanley & Co. LLC in 1986.
Consultant at McKinsey & Co., Inc. from 1973 to 1975.
President at Genentech Development Corp.
Education includes undergraduate degree from Massachusetts Institute of Technology in 1971 and MBA from Harvard Business School in 1973.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
09-07-2026 8.938 ( 129,54% ) 19 127 $ 31-08-2026

Actieve functies van Fred Middleton

BedrijvenFunctieBegin
Private Equity Investor 01-11-1987
Directeur/Bestuurslid 01-01-2008
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Middleton, McNeil & Mills Associates V LLC
Corporate Officer/Principal -
Directeur/Bestuurslid 01-01-2008
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid 01-01-2007
░░░░ ░░░░░ ░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ -

Eerdere bekende functies van Fred Middleton

BedrijvenFunctieEinde
░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Fred Middleton in detail bekijken

Opleiding van Fred Middleton

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

64

Eerstegraads connecties

30

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit30

Health Technology

Health Technology

Finance

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Middleton, McNeil & Mills Associates V LLC

Health Technology

Finance

Health Technology

Health Services

Health Technology

Finance

Commercial Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Genentech Development Corp.

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Fred Middleton
40 % korting: de beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU